Supporting efficacy and scaling with a next-generation T cell AOF formulation medium

Alan Gutowski, Product Manager, and Joanna Kern, Scientist, discuss a novel, next-generation medium with an animal component-free formulation developed to help increase therapeutic potential and to support the cell therapy industry’s need for consistent, reproducible, and automated T cell manufacturing.